This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.
Clinical trial NCT03483077 · TERMINATED
Trial details
- NCT number
- NCT03483077
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2019-03-21
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.